MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, ARDX made $407,320K in revenue. -$61,458K in net income. Net profit margin of -15.09%.

Income Overview

Revenue
$407,320K
Net Income
-$61,458K
Net Profit Margin
-15.09%
EPS
-$0.26
Unit: Thousand (K) dollars
Revenue Breakdown
    • Product IBSRELA
    • Product XPHOZAH
    • Kyowa Kirin Co.Ltd-License Agree...
    • Others
Revenue Breakdown
    • Product
    • Product Supply Revenue
    • Non Cash Royalty Related To Sale...
    • License
Revenue Breakdown
    • US
    • Asia Pacific
    • North America
Revenue Breakdown
    • Product
    • Product And Service Other

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-12-31
2024-12-31
Total revenues
407,320 333,615
Cost of sales
39,537 50,556
Research and development
71,527 52,317
Selling, general and administrative
337,233 258,692
Total costs and operating expenses
448,297 311,009
Loss from operations
-40,977 -27,950
Interest expense
20,102 13,006
Non-cash interest expense related to the sale of future royalties
8,296 7,088
Other income, net
8,745 9,174
Loss before provision for income taxes
-60,630 -38,870
Provision for income taxes
969 266
Net loss
-61,599 -39,136
Unrealized gains (losses) on available-for-sale securities
141 -167
Comprehensive loss
-61,458 -39,303
Net loss per share of common stock - basic (in dollars per share)
-0.26 -0.17
Net loss per share of common stock - diluted (in dollars per share)
-0.26 -0.17
Shares used in computing net loss per share - basic (in shares)
241,033,750 235,232,927
Shares used in computing net loss per share - diluted (in shares)
241,033,750 235,232,927
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$61,458K Unrealized gains (losses)on...$141K Net loss-$61,599K Knight TherapeuticsInc-License Agreement...$88K License AgreementDevelopment...$5,000K Knight TherapeuticsInc-License Agreement...$254K Kyowa KirinCo.Ltd-License Agreement...$15,625K Product XPHOZAH$103,601K Product IBSRELA$274,207K Provision for income taxes$969K Loss beforeprovision for income taxes-$60,630K Other income, net$8,745K Non Cash RoyaltyRelated To Sale Of Future...$8,545K License$5,088K Product Supply Revenue$15,879K Product$377,808K Non-cash interestexpense related to the...$8,296K Interest expense$20,102K Loss from operations-$40,977K Total revenues$407,320K Total costs andoperating expenses$448,297K Selling, general andadministrative$337,233K Research and development$71,527K Cost of sales$39,537K

ARDELYX, INC. (ARDX)

ARDELYX, INC. (ARDX)